Marbonor Injection
Marbonor Injection is an antimicrobial solution for injection containing marbofloxacin. It is indicated for the treatment of respiratory infections and acute mastitis in cattle and the treatment of metritis mastitis agalactia syndrome (postpartum dysgalactia syndrome, PDS) in pigs.
Target Species: Beef cattle, dairy cattle, pigs
-
Active Ingredient
Each ml contains: Marbofloxacin 100.0 mg
-
Pharmaceutical Form
Solution for injection. Clear yellow to amber solution.
-
Indications
Cattle: Treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica and Mycoplasma bovis. Treatment of acute mastitis caused by Echerichia coli strains sensitive to marbofloxacin during the lactation period. Sows: Treatment of Metritis Mastitis Agalactia Syndrome (postpartum dysgalactia syndrome, PDS) caused by bacterial strains sensitive to marbofloxacin.
-
Dosage
To ensure administration of a correct dose, bodyweight should be determined as accurately as possible to avoid underdosing. The recommended dosage is 2 mg/kg (1 ml/50kg) in a single daily injection by intramuscular, subcutaneous or intravenous routes in cattle and by intramuscular route in pigs. For the injections, the neck should be preferred in cattle and pigs. Treatment durations are 3 days in pigs and 3 to 5 days in cattle. The vial may be broached up to 35 times. The user should choose the most appropriate vial size according to the target species to be treated.
Prefer to speak directly to a member of our team?
Norbrook GBÂ
We are open. Mon - Fri 9:00am - 5:00pm
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.